Skip to content

Congenital Lung Abnormalities on MRI

Congenital Lung Abnormalities on MRI: the CLAM study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22444
Enrollment
42
Registered
2018-04-24
Start date
2018-10-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Magnetic Resonance Imaging, Cine Cystic Adenomatoid Malformation of Lung, Congenital

Interventions

MRI Lungfunction test

Sponsors

Erasmus Medical Center, Sophia Children's Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Radiological or if resected pathological diagnosis of CPAM - Enrolment in CHIL follow-up program - Age &#8805; 8 years and < 18 years at the start of the study - Signed informed consent by parents and/or patient

Exclusion criteria

Exclusion criteria: - Contra- indications for MRI - Cognitive impairment preventing adherence to breathing instructions - Presence of associated anomalies in chest cavity which might skew results according to primary physician - Claustrofobia

Design outcomes

Primary

MeasureTime frame
The main study endpoints are the MRI features of the lungs both before and after resection of CPAM and its correlation to lung function.

Secondary

MeasureTime frame
Secondary endpoint is the MRI scan protocol in which optimal imaging of lung parenchyma and abnormalities is achieved. Furthermore, the difference in lung function between surgically and conservatively treated patients as well as their relation to imaging characteristics including volume of the abnormality.

Contacts

Public ContactH.A.W.M. Tiddens

Erasmus Medical Center, Sophia Children’s Hospital Rotterdam, Department of Pediatric Pulmonology, Dr. Molewaterplein 60

h.tiddens@erasmusmc.nl+31 (0)10 4636690 / +31 (0)10 4636363 (general)

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)